RUNX3 is required to promote chromatin accessibility to genes encoding IRF4 and Blimp transcription factors for CD8+ memory T cells, so it will be of great interest to compare the epigenetic landscapes between CD8+ TCM and CD8+ TRM cells under various tumor settings. The gene discussed is CD8A; the disease is neoplasm.